Skyline Advisors
  • Services
  • Team
  • Transactions
  • Industries
  • Reports
  • News
    • Capital Markets
    • Firm News
    • Resources
  • Contact
    • Newsletter

Partners for Strategic Transactions

Swiss Drugmaker Roche to Buy US-Based Ignyta

12/23/2017

0 Comments

 
Roching Holdings (SWX: RO), a Swiss developer of pharmaceutical and therapeutic medicines used in oncology, has agreed to acquire Ignyta (NASDAQ: RXRX), a US developer of personalized-medicine therapies designed for autoimmune diseases. 
Picture
Picture
The $1.7 billion offer will allow Roche to execute on its strategy of fitting treatments to patients and to broaden its oncology portfolio globally. At $27 per share, the offer represents a 74% premium to Ignyta’s closing price on Thursday.
​
The deal is expected to close in the first half of 2018.
0 Comments



Leave a Reply.

    Archives

    March 2019
    December 2018
    April 2018
    February 2018
    December 2017

    Categories

    All
    Healthcare
    Mergers And Acquisitions

    RSS Feed

Picture
​Skyline Advisors is a division of Ideation Ventures, Inc. Services involving securities are offered through M&A Securities Group, Inc.4151 N Mulberry Drive Suite 252, Kansas City, MO, 64116  (“MAS") . Services involving real estate brokerage are offered through Berkshire Hathaway HomeServices Ambassador Real Estate ("BHHS"). Skyline, MAS, and BHHS are separate entities. 
​

COPYRIGHT 2020. ALL RIGHTS RESERVED.
Virtual Data Room
Company   Services   Team   Transactions   Industries   Reports   News
Photo used under Creative Commons from inkknife_2000 (8.5 million views +)
  • Services
  • Team
  • Transactions
  • Industries
  • Reports
  • News
    • Capital Markets
    • Firm News
    • Resources
  • Contact
    • Newsletter